University of California San Diego researchers have discovered the enzyme responsible for chromothripsis, a process in which ...

Scientists discovered that certain cancer cells use a low-level activation of a DNA-dismantling enzyme—normally seen in cell ...

University of California San Diego researchers have discovered the enzyme responsible for chromothripsis, a process in which a single chromosome is shattered into pieces and rearranged in a scrambled ...

Bananas are packed with PPO. This enzyme is the reason an apple turns brown when you slice it and leave it out. That browning ...

Rapafusyn Pharmaceuticals, a biotechnology company advancing next-generation molecular glue therapeutics for hard-to-drug targets, today announced that its founder, Dr. Jun O. Liu of the Johns Hopkins ...

Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing next-generation oncology therapies, ...

In chronic spontaneous urticaria, InflaRx observed substantial reductions in the 7-day Urticaria Activity Score (UAS7) broadly across patients and particularly in those with severe disease, as well as ...

The first-line standard of care for HR-positive/HER2-negative breast cancer is cyclin-dependent kinase (CDK)4/6 inhibitors ...

Trastuzumab deruxtecan (T-DXd; Enhertu), is a HER2-targeting ADC that is used in ET-treated HER2-low or HER2-ultralow disease ...

Here's a look at scientific discoveries and breakthroughs that made headlines in 2025, spanning space, biology, ecology, and ...

Biomanufacturing is a growing $500 billion industry that uses living systems such as algae to produce things such as ...

Ateganosine (THIO, 6-thio-2'-deoxyguanosine), a first-in-class telomere-targeting therapy under development by MAIA ...